This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Feb 3;80(2):603-604.

doi: 10.1093/jac/dkae435.

Comment on: prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium

Affiliations

PMID: 39658214
DOI: 10.1093/jac/dkae435

Editorial

Comment on: prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium

Kenyon Chris. J Antimicrob Chemother. 2025.

. 2025 Feb 3;80(2):603-604.

doi: 10.1093/jac/dkae435.

Author

Affiliation

¹ Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000, Antwerp, Belgium.

PMID: 39658214
DOI: 10.1093/jac/dkae435

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interests None declared.

Comment on

Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.
Ando N, Mizushima D, Takano M, Mitobe M, Kobayashi K, Kubota H, Miyake H, Suzuki J, Sadamasu K, Aoki T, Watanabe K, Oka S, Gatanaga H. Ando N, et al. J Antimicrob Chemother. 2025 Jan 3;80(1):247-253. doi: 10.1093/jac/dkae403. J Antimicrob Chemother. 2025. PMID: 39499214

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems